Sadayoshi Ito

ORCID: 0000-0002-5092-3626
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hormonal Regulation and Hypertension
  • Blood Pressure and Hypertension Studies
  • Chronic Kidney Disease and Diabetes
  • Renin-Angiotensin System Studies
  • Renal and Vascular Pathologies
  • Adrenal and Paraganglionic Tumors
  • Renal Diseases and Glomerulopathies
  • Dialysis and Renal Disease Management
  • Nitric Oxide and Endothelin Effects
  • Adrenal Hormones and Disorders
  • Electrolyte and hormonal disorders
  • Eicosanoids and Hypertension Pharmacology
  • Cardiovascular Health and Disease Prevention
  • Renal function and acid-base balance
  • Sodium Intake and Health
  • Ion Transport and Channel Regulation
  • Diet and metabolism studies
  • Liver Disease Diagnosis and Treatment
  • Advanced Glycation End Products research
  • Heart Rate Variability and Autonomic Control
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Peroxisome Proliferator-Activated Receptors
  • Pituitary Gland Disorders and Treatments
  • Adipose Tissue and Metabolism

Tohoku University
2016-2025

Tohoku University Hospital
2014-2023

The University of Tokyo
1999-2022

Niigata University
1980-2022

Tohoku Medical Megabank Organization
2016-2021

Mamata General Hospital
2020

Center for Vascular Biology Research
2002-2019

Otto-von-Guericke University Magdeburg
2019

Nagoya City University
1995-2018

Japanese Society of Nephrology
2018

In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis rat L6 myotubes treated with PPARδ subtype-selective agonist, GW501516, Affymetrix oligonucleotide microarrays revealed that controls fatty acid oxidation regulating genes involved transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed skeletal muscle GW501516-treated mice....

10.1073/pnas.0306981100 article EN Proceedings of the National Academy of Sciences 2003-12-15

Microalbuminuria is an early predictor of diabetic nephropathy and premature cardiovascular disease. We investigated whether treatment with angiotensin-receptor blocker (ARB) would delay or prevent the occurrence microalbuminuria in patients type 2 diabetes normoalbuminuria.

10.1056/nejmoa1007994 article EN New England Journal of Medicine 2011-03-09

Objective To compare the predictive powers of self-measurement blood pressure at home (home measurement) and casual (screening) measurement for mortality. Design A prospective cohort study. Subjects methods We obtained screening measurements 1789 subjects aged ≥ 40 years who were followed up a mean 6.6 years. The prognostic significance mortality was determined by Cox proportional hazards regression model adjusted age, sex, smoking status, past history cardiovascular disease, use...

10.1097/00004872-199816070-00010 article EN Journal of Hypertension 1998-07-01

Abstract —To investigate the association between cardiovascular mortality and short-term variabilities in blood pressure heart rate, we performed a long-term prospective study of ambulatory monitoring Ohasama, Japan, starting 1987. We obtained rate 1542 subjects ≥40 years age. Blood were estimated as standard deviation measured every 30 minutes by monitoring. There 67 deaths during follow-up period (mean=8.5 years). The Cox proportional hazards model, adjusted for possible confounding...

10.1161/01.hyp.36.5.901 article EN Hypertension 2000-11-01

In this prospective, randomized, open-label, blinded end point study, we aimed to establish whether strict blood pressure control (<140 mm Hg) is superior moderate (≥140 Hg <150 in reducing cardiovascular mortality and morbidity elderly patients with isolated systolic hypertension. We divided 3260 aged 70 84 years hypertension (sitting 160 199 into 2 groups, according or treatment. A composite of events was evaluated for ≥2 years. The (1545 patients) (1534 groups were well matched...

10.1161/hypertensionaha.109.146035 article EN Hypertension 2010-06-08

Phaeochromocytomas (PHEO) and paragangliomas are rare catecholamine-producing tumours. Although 10-30% of these tumours metastasise, histopathological criteria to discriminate malignant from benign have not been established; therefore, reliable markers predicting metastasis urgently required. A total 163 tumours, including 40 metastatic collected by the Phaeochromocytoma Study Group in Japan (PHEO-J) were analysed using a system called grading for adrenal phaeochromocytoma paraganglioma...

10.1530/erc-13-0494 article EN Endocrine Related Cancer 2014-02-12

Rationale & ObjectiveEpidemiologic and clinical studies have suggested that urate-lowering therapy may slow the progression of chronic kidney disease (CKD). However, definitive evidence is lacking.Study DesignRandomized, double-blind, placebo-controlled trial.Setting Participants467 patients with stage 3 CKD asymptomatic hyperuricemia at 55 medical institutions in Japan.InterventionParticipants were randomly assigned a 1:1 ratio to receive febuxostat or placebo for 108 weeks.OutcomesThe...

10.1053/j.ajkd.2018.06.028 article EN cc-by-nc-nd American Journal of Kidney Diseases 2018-08-31

The Great East Japan Earthquake (GEJE) and resulting tsunami of March 11, 2011 gave rise to devastating damage on the Pacific coast Tohoku region. Medical Megabank Project (TMM), which is being conducted by University Organization (ToMMo) Iwate (IMM), has been launched realize creative reconstruction solve medical problems in aftermath this disaster. We started two prospective cohort studies Miyagi Prefectures: a population-based adult study, TMM Community-Based Cohort Study (TMM CommCohort...

10.2188/jea.je20150268 article EN cc-by Journal of Epidemiology 2016-01-01

Diabetic kidney disease is a major cause of renal failure that urgently necessitates breakthrough in management. Here we show using untargeted metabolomics levels phenyl sulfate, gut microbiota-derived metabolite, increase with the progression diabetes rats overexpressing human uremic toxin transporter SLCO4C1 kidney, and are decreased limited proteinuria. In experimental models diabetes, sulfate administration induces albuminuria podocyte damage. diabetic patient cohort, significantly...

10.1038/s41467-019-09735-4 article EN cc-by Nature Communications 2019-04-23

MDA5 is an essential intracellular sensor for several viruses, including picornaviruses, and elicits antiviral interferon (IFN) responses by recognizing viral dsRNAs. has been implicated in autoimmunity. However, the mechanisms of how contributes to autoimmunity remain unclear. Here we provide direct evidence that dysregulation caused autoimmune disorders. We established a mutant mouse line bearing mutation ENU mutagenesis, which spontaneously developed lupus-like symptoms without infection....

10.1016/j.immuni.2013.12.014 article EN publisher-specific-oa Immunity 2014-02-01

A significant link has been reported between aortic stiffening and renal microvascular damage, but the underlying mechanism remains poorly understood. We hypothesized that alterations in central hemodynamics are responsible for this link. In 133 patients with hypertension, pressure waveforms were recorded on radial, carotid, femoral, dorsalis pedis arteries applanation tonometry to estimate pressures (carotid-femoral) peripheral (carotid-radial femoral-dorsalis pedis) pulse wave velocities....

10.1161/hypertensionaha.111.177469 article EN Hypertension 2011-10-04

The renal and cardiovascular protective effects of angiotensin receptor blocker (ARB) remain controversial in type 2 diabetic patients treated with a contemporary regimen including an converting enzyme inhibitor (ACEI). We examined the olmesartan, ARB, on primary composite outcome doubling serum creatinine, endstage disease death overt nephropathy. Secondary included outcomes, changes function proteinuria. Randomisation allocation to trial group were carried out by central computer system....

10.1007/s00125-011-2325-z article EN cc-by-nc Diabetologia 2011-10-12
Toshio Ogihara Kenjiro Kikuchi Toshiro Fujita Jitsuo Higaki Masatsugu Horiuchi and 95 more Yutaka Imai Tsutomu Imaizumi Toshihiko Ishimitsu Sadayoshi Ito Hiroshi Iwao Kazuomi Kario Yuhei Kawano Shokei Kim Genjiro Kimura Hiroaki Matsubara Hiroyuki Matsuoka Hideo Matsuura Mitsuhide Naruse Hiromi Rakugi Ikuo Saito Kazuyuki Shimada Kazuaki Shimamoto Hiromichi Suzuki Shuichi Takishita Norio Tanahashi Takuya Tsuchihashi Makoto Uchiyama Shinichiro Ueda Hirotsugu Ueshima Satoshi Umemura Ichiro Hisatome Shigehiro Katayama Toru Kita Masayasu Matsumoto Kazuwa Nakao Tetsuo Nishikawa Yasuyoshi Ouchi Tamio Teramoto Mineo Yamasaki Hitoshi Yokoyama Isao Abe Katsuyuki Ando Mikio Arita Yoshinori Doi Fumitake Gejyo Atsuo Goto Naoyuki Hasebe Kôichi Hayashi Yasunobu Hirata Yukio Hirata Nobuhito Hirawa Yoshitaka Hirooka Takeshi Horio Kunitoshi Iseki Hiroyasu Iso Masaaki Ito Takayuki Ito Hiroshi Itoh Hisashi Kai Kei Kamide Naoki Kashihara Atsunori Kashiwagi Tomohiro Katsuya Toru Kikuchi Kenjiro Kimura K. Kitamura Yutaka Kiyohara Shotai Kobayashi Katsuhiko Kohara Masakazu Kohno Issei Komuro Hiroo Kumagai Toshio Kushiro Iwao Kuwajima Hirofumi Makino Masunori Matsuzaki Junichi Minami Isamu Miyamori Shigeto Morimoto Toyoaki Murohara Koichi Node Hisao Ogawa Yusuke Ohya Yoshihiko Saito Hakuo Takahashi Shori Takahashi Kenji Takazawa Kouichi Tamura Osamu Tochikubo Yasuhiko Tomino Kimio Tomita Yoshiharu Tsubakihara Hiroyuki Tsutsui Shinichiro Uchiyama Yoshio Uehara Nobuyuki Ura Hidenori Urata Tsuyoshi Watanabe Hiroyuki YAMADA Akira Yamashina

10.1038/hr.2014.3 article EN Hypertension Research 2014-04-01

Gut microbiota is involved in the metabolism of uremic solutes. However, precise influence to retention solutes CKD obscure. To clarify this, we compared adenine-induced renal failure and control mice under germ-free or specific pathogen-free (SPF) conditions, examining metabolite profiles plasma, feces, urine using a capillary electrophoresis time-of-flight mass spectrometry-based approach. Mice with conditions demonstrated significant changes plasma metabolites. Among 183 detected solutes,...

10.1016/j.kint.2017.02.011 article EN cc-by-nc-nd Kidney International 2017-04-08
Coming Soon ...